Nigeria: NAFDAC Eliminates Counterfeit Goods Valued at N16 Billion

Nigeria: NAFDAC Eliminates Counterfeit Goods Valued at N16 Billion

By Ahmad Hadizat Omayoza, Mamos Nigeria
In a significant effort to safeguard public health, the National Agency for Food and Drug Administration and Control (NAFDAC) has disclosed the destruction of 135 truckloads of fake, counterfeit, spurious, and damaged or expired products. The estimated street value of these disposed goods stands at a staggering N16 billion. Prof. Mojisola Adeyeye, the Director General of NAFDAC, made this announcement during the 2023 End of Year Parley in Abuja.
As part of its ongoing commitment to ensuring the safety of consumers, NAFDAC initiated raids in the South-East and South-South regions, spanning nine states. During these operations, counterfeit Diageo products worth over N38 million were successfully recovered. Similar efforts were undertaken in Lagos State and Abuja, resulting in the seizure of counterfeited products valued at over N200 million.
Prof. Mojisola Adeyeye detailed the initiation of a phased ban on pesticides in the country. The ban encompasses pesticides such as Paraquat, Chlorpyrifos, Atrazine, and 12 active ingredients, including Carbofuran, Clothianidin, Diquat Dibromide, Diquate Dichloride, Ametryn, Anthraquinone, Carbendazim, Chlorothalonil, Oxadiargyle, Thiacloprid, Methomyl, and Thiamethoxam.
Commencing on January 1, 2024, the ban begins with Paraquat, followed by Chlorpyrifos on November 1, 2024, and Atrazine on January 1, 2025. Additionally, NAFDAC plans to reclassify four other pesticides—Fipronil, Permethrin, Cyfluthrin, and Amitraz.
During her address, Prof. Adeyeye highlighted the commencement of digitization efforts for a structured database of NAFDAC-approved human medicines from 2018 to date. This initiative, carried out by the ICT Unit, aims to provide comprehensive Anatomical Therapeutic Chemical (ATC) Classification based on WHO ATC. The registered drug product database is accessible on both web and mobile app platforms, offering the public easy access to information on drugs registered by the agency.
In terms of regulatory processes, the Investigation and Enforcement Directorate has actively conducted joint inspection, seizures, and destruction exercises targeting banned or unregistered products. These efforts align with NAFDAC’s commitment to maintaining high standards and protecting consumers from substandard and harmful products.
Prof. Adeyeye also reported on NAFDAC’s pursuit of achieving Maturity Level 4 by the next year, following a successful visit by the World Health Organization (WHO) Audit team. The GBT WHO Audit team monitored three regulatory processes, namely Regulatory Inspection, Market Authorization, and Laboratory Testing, resulting in a successful audit.
Furthermore, NAFDAC has actively engaged in capacity building for sister agencies in Africa, welcoming Botswana and Uganda for an understudy on traceability. This collaborative effort, known as Reliance, reflects NAFDAC’s dedication to fostering relationships with other regulatory agencies globally, including US FDA, UK VET, TGA, MHRA, South Korea NRA, Saudi Arabia FDA, South Africa SAHPRA, and Egypt EDA.
As NAFDAC continues its relentless pursuit of regulatory excellence, the public remains hopeful for the continued success and impact of these vital initiatives.

Post a Comment

Translate »